Author:
Güney İsa Burak,Küçüker Kadir Alper
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference49 articles.
1. 1.Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Rosary CL et al. SEER Cancer Statistics Review, 1975-2014, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2014/, based on November 2016 SEER data submission, posted to the SEER web site, April 2017.
2. 2.Rigel DS, Friedman RJ, Kopf AW. The incidence of malignant melanoma in the United States: issues as we approach the 21st century. J AmAcad Dermatol, 1996; 34(5): 839-847. 3.Scolyer RA, Thompson JF, Stretch JR, Sharma R, McCarthy SW. Pathology of melanocytic lesions: new, controversial, and clinically important issues. J Surg Oncol, 2004; 86: 200-11.
4.Swetter SM, Smoller BR, Bauer EA. Cutaneous cancer and malignant melanoma. In: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE, eds. Clinical Oncology. New York, NY: Churchill Livingstone; 1995: 1027-1033.
3. 5.Scolyer RA, Murali R, McCarthy SW, Thompson JF. Pathologic examination of sentinel lymph nodes from melanoma patients. Semin Diagn Pathol, 2008; 25:100-11.
4. 6.Morton DL, Wanek L, Nizze JA, Elashoff RM, Wong JH. Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes: analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic. Ann Surg, 1991; 214(4): 491-499.
5. 7.Cochran AJ, Lana AM, Wen DR. Histomorphometry in the assessment of prognosis in stage II malignant melanoma. Am J Surg Pathol, 1989; 13(7): 600-604.